Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer (REALME)

This study has suspended participant recruitment.
(Difficulty in enrolling patients)
Sponsor:
Information provided by (Responsible Party):
National Guard Health Affairs
ClinicalTrials.gov Identifier:
NCT01320501
First received: March 19, 2011
Last updated: May 12, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)